Xylazine for Animals

Xylazine

Xylazine is an alpha2-adrenergic agonist providing sedation, muscle relaxation and a shorter period of analgesia. It is used for restraint, standing procedures and balanced anesthesia in several veterinary species. Ruminants are particularly sensitive to its pharmacologic effects. A separate small-animal application is induction of emesis in selected cats.

Group

Alpha2-adrenergic sedative and analgesic

Mechanism of Action

Xylazine stimulates central alpha2-adrenoceptors, reducing norepinephrine release and activity in arousal pathways. Alpha2 effects in the spinal cord and other pain pathways reduce nociceptive transmission, while central actions promote muscle relaxation. These effects produce sedation and analgesia without complete general anesthesia. Stimulation of alpha2-sensitive emetic pathways can also trigger vomiting in cats.

Dose Rates

Dogs

Use / stageDoseRouteScheduleInstructions
Sedation1.1 mg/kgIVOnce
Sedation2.2 mg/kgIMOnce
Short-term pain0.1–0.5 mg/kgIM, IV, SC
Sedation label alternative1.1–2.2 mg/kgIM, SCOnceOlder label range often considered high; titrate conservatively.
Preanesthetic sedation0.2–1 mg/kgIV, IM, SCOnce
Analgesia alternative0.1–1 mg/kgIV, IM, SC
Postoperative anxiety0.1–0.5 mg/kgIV, IM, SC
Epidural analgesia0.02–0.25 mg/kgEPIDURALDilute with sterile saline to 0.26 mL/kg total injection; onset 20-30 minutes and duration 2-5 hours. Exact sterile preparation/excipients must suit epidural use.

Cats

Use / stageDoseRouteScheduleInstructions
Short-term pain0.1–0.5 mg/kgIM, IV, SC
Sedation1.1 mg/kgIM, IVOnce
Emesis0.4–0.5 mg/kgIM, IVOnce
Sedation label alternative1.1–2.2 mg/kgIM, SCOnceOlder label range often considered high; titrate conservatively.
Preanesthetic sedation0.2–1 mg/kgIV, IM, SCOnce
Analgesia alternative0.1–1 mg/kgIV, IM, SC
Postoperative anxiety0.1–0.5 mg/kgIV, IM, SC
Emesis0.44 mg/kgIMOnce

Horses

Use / stageDoseRouteScheduleInstructions
Sedation1–2 mg/kgIMOnce
Standing restraint0.5–1 mg/kgIV, IOOnce
Sedative infusion — Loading0.5–1.1 mg/kgIVOnce
Sedative infusion — Maintenance0.72–1 mg/kg/hourIVContinuousReported regimen describes infusions up to 6 hours.
Colic pain0.3–0.5 mg/kgIV
Triple-drip anesthesiaReference onlyIV500 mg xylazine plus 2 g ketamine in 1 L 5% guaifenesin in dextrose: induction 1.1 mL/kg then 2-4 mL/kg/hour. Recovery about 25-30 minutes; reported mentions yohimbine 0.125 mg/kg for faster recovery without stating reversal route for this regimen. Preserve the combined fluid protocol.
Colic pain0.2–0.5 mg/kgIV
Colic pain0.6–1 mg/kgIM
Sedation and analgesia0.2–1.1 mg/kgIV, IM
Caudal epidural analgesia0.03–0.35 mg/kgEPIDURALFirst coccygeal space; perineal sweating common, reported duration 3-5 hours.
Lumbosacral catheter analgesia0.2 mg/kgEPIDURAL

Pigs

Use / stageDoseRouteScheduleInstructions
Sedation0.5–3 mg/kgIMOnceUnreliable alone; reported example combines xylazine 2 mg/kg with ketamine 10 mg/kg.

Cattle

Use / stageDoseRouteScheduleInstructions
Sedation0.1–0.2 mg/kgIMOnce
Sedation0.03–0.1 mg/kgIVOnce
Sedation0.1–0.3 mg/kgIMOnce
Sedation0.05–0.15 mg/kgIVOnce
Epidural analgesia0.05–0.07 mg/kgEPIDURAL

Sheep

Use / stageDoseRouteScheduleInstructions
Sedation0.1–0.3 mg/kgIMOnce
Sedation0.05–0.1 mg/kgIVOnce
Light standing sedation0.01 mg/kgIVOnce
Recumbent sedation0.2 mg/kgIMOnceUse 20 mg/mL preparation; marked species sensitivity.

Goat

Use / stageDoseRouteScheduleInstructions
Sedation0.05–0.5 mg/kgIMOnce
Sedation0.01–0.5 mg/kgIVOnce
Light standing sedation0.01 mg/kgIVOnce
Recumbent sedation0.2 mg/kgIMOnceUse 20 mg/mL preparation; marked species sensitivity.

Ferrets

Use / stageDoseRouteScheduleInstructions
Sedation or analgesia0.5–2 mg/kgIM, SCOften a combination with antimuscarinic or opioid.

Birds

Use / stageDoseRouteScheduleInstructions
Sedative adjunct1–4 mg/kgIMFor ketamine anesthesia; avoid debilitated birds due to cardiac depression.

Indications

  • Sedation and chemical restraint for examinations or procedures in horses, ruminants, dogs, cats and selected wildlife species.
  • Preanesthetic medication or adjunctive sedation and analgesia within balanced anesthetic protocols.
  • Short-term relief of selected equine visceral pain, including colic-associated pain during evaluation and treatment.
  • Caudal epidural analgesia for selected obstetric, perineal or hindquarter procedures with a supported species-specific protocol.
  • Induction of emesis after selected recent toxicant ingestion in cats when vomiting is the intended decontamination method.

Contraindications

  • Cardiac disease
  • Pregnancy, especially late gestation, requires caution.
  • Ruminants require much lower amounts than dogs or horses.

Interactions

  • Opioids and other sedatives increase depression; avoid other important cardiac depressants and vasodilating phenothiazines.

Adverse effects

  • Vomiting, ataxia, bradycardia/AV block, initial hypertension then hypotension, hyperglycemia, decreased gut motility and ruminant bloat/regurgitation.

Toxicity

Overdose can cause profound CNS/respiratory depression, bradyarrhythmias, hypotension or seizures. Support ventilation and perfusion and consider a suitable alpha2 antagonist.

Preparations

PreparationFormStrengthRoute
Xylazine injection 20 mg/mLInjection20 mg / mLIV, IM, SC, IO
Xylazine injection 100 mg/mLInjection100 mg / mLIV, IM, SC, IO

Monitoring and Administration

Monitor rhythm, perfusion, ventilation, regurgitation and recovery. Lower equine doses favor standing restraint; draft horses can be more sensitive. Routine atropine premedication is not required solely for the expected low pulse.

Significant adverse effects can be reversed with an appropriate alpha2 antagonist.

Combined epidural protocols include dogs xylazine 0.02 mg/kg plus morphine 0.1 mg/kg to 0.26 mL/kg, and horses xylazine 0.17 mg/kg plus lidocaine 0.22 mg/kg in the first coccygeal space; recumbency/ataxia may occur. Do not assign these combined durations to xylazine alone.

Small-mammal anesthesia combinations: rabbits ketamine 35 + xylazine 5 mg/kg IM, or ketamine 25 + xylazine 5 with butorphanol 0.1 or acepromazine 1 mg/kg IM. IP combinations include gerbil ketamine 50/xylazine 2, guinea pig 40/5, hamster 200/10, mouse 80/10 and rat 75/10 mg/kg; an alternative rodent protocol uses xylazine 5/ketamine 50/atropine 0.05 mg/kg IP. These are joint protocols, not isolated sedative regimens.

Bovine standing BXK combination: butorphanol 0.01-0.025, xylazine 0.02-0.05 and ketamine 0.04-0.1 mg/kg IM. Initial suggested totals for animals above 450 kg are no more than butorphanol 10 mg and xylazine 20 mg. Camelid IM combination: alpaca butorphanol 0.046/xylazine 0.46/ketamine 4.6 mg/kg; llama 0.037/0.37/3.7 mg/kg. Up to half the original ketamine/xylazine amounts may extend anesthesia; no final compounded-vial mL concentration is inferred.

Scroll to Top